Preview Mode Links will not work in preview mode

Nov 30, 2021

Featuring perspectives from Dr Stephen Ansell and Ms Robin Klebig, including the following topics:

  • Diffuse Large B-Cell Lymphoma (DLBCL)
    • Introduction (0:00)
    • Key Recent FDA Approvals for DLBCL (1:30)
    • Case: A woman in her early 80s with relapsed DLBCL (21:07)
  • Hodgkin Lymphoma
    • Novel Agents and Combination Therapies for the Management of Hodgkin Lymphoma (22:48)
    • Case: A man in his late 70s with newly diagnosed Hodgkin lymphoma (30:54)
  • Follicular Lymphoma
    • Key Recent Pivotal Data Sets/FDA Approvals for Follicular Lymphoma (36:01)
    • Case: A man in his mid-70s with newly diagnosed follicular lymphoma (39:23)
  • Mantle Cell Lymphoma
    • Key Recent Developments in Mantle Cell Lymphoma (44:45)
    • Case: A woman in her early 60s with relapsed/refractory mantle cell lymphoma (54:23)

NCPD information and select publications